Press Releases

Date	Title	Company
10-Nov-2023	Pharmaceutical Intermediates Market is set to expand with a 4.3% CAGR by 2030, focusing on ensuring drug safety and efficacy, according to FMI	MARKITWIRED
10-Nov-2023	Skincare Market Sets New Record, Predicted to Hit USD 273.3 Billion by 2031 at 6.7% CAGR: Allied Market Research	The Wire Times
10-Nov-2023	Disposable Spinal Instruments Market is on track to reach US$ 96.5 Million by 2028, driven by the surging demand for minimally invasive surgeries, according to FMI	MARKITWIRED
10-Nov-2023	Home Sleep Screening Devices Market ascent to US$ 11.4 Billion by 2032 is fueled by the growing desire for convenient solutions \| FMI	MARKITWIRED
10-Nov-2023	Smart Inhalers Market Sets New Record, Predicted to Hit USD 1.1 Billion by 2030 at 25.1% CAGR : AMR	The Wire Times
10-Nov-2023	Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences	Formycon AG
10-Nov-2023	Skin Perfusion Pressure Testing Devices Market is set to experience a 4.5% CAGR through 2030 \| FMI	MARKITWIRED
10-Nov-2023	Retail Clinics Market is poised for substantial growth, projecting a CAGR of 9.6% by 2028, according to FMI	MARKITWIRED
10-Nov-2023	Gastroesophageal Reflux Disease (GERD) Devices Market is poised to reach a valuation of US$ 1.5 billion by 2028 \| FMI	MARKITWIRED
10-Nov-2023	Takeda recibe la aprobación de la FDA de EE. UU. del FRUZAQLA™ (fruquintinib) para el cáncer colorrectal metastásico previamente tratado	Businesswire
10-Nov-2023	Takeda erhält US-Zulassung der FDA für FRUZAQLA™ (Fruquintinib) zur Behandlung von metastasiertem Dickdarmkrebs	Businesswire
10-Nov-2023	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance	Businesswire
10-Nov-2023	OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event	Businesswire
10-Nov-2023	Mitral Valve Disease Market Trends : is Expected to Attain USD 5.7 billion by 2031 , Claims AMR	The Wire Times
10-Nov-2023	Thermo Fisher Scientific Declares Quarterly Dividend	Businesswire
10-Nov-2023	Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results	Businesswire
10-Nov-2023	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Businesswire
10-Nov-2023	Takeda obtient l’approbation de la FDA des États-Unis pour le FRUZAQLA™ (fruquintinib) dans le traitement du cancer colorectal métastatique déjà traité	Businesswire
10-Nov-2023	Model N Announces Fourth Quarter and Fiscal Year 2023 Financial Results	Businesswire
10-Nov-2023	Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights	Businesswire